KineMed's Series F Round

KineMed raised a round of funding on November 10, 2011. Investors include Ledgemont Capital Group.

KineMed employs both pathway-based drug discovery and translational medicine-enabled drug development. KineMed's pathway-based discovery is based upon its ability to identify drugs with therapeutic ef…

Articles about KineMed's Series F Round: